SP-CAT-047

C-Peptide, Human, CAS: 33017-11-7

US$315.00

Excluding tax and shipping fees

In stock

Description

About C-Peptide, Human, CAS: 33017-11-7

C-Peptide (human) or connecting peptide is a short peptide that connects the A- and B-chains of insulin in proinsulin molecule, a precursor of insulin. After proinsulin is packaged into vesicles in the Golgi apparatus, the C-peptide is removed, leaving the A-chain and B-chain bound together by disulfide bonds that constitute the insulin molecule. In diabetes patients, the C-peptide levels in blood serum are used for diagnosis. For research use only, do not use in humans!

C-Peptide, Human, CAS: 33017-11-7 - Specifications

Peptide sequence: H-EAEDLQVGQVELGGGPGAGSLQPLALEGSLQ-OH
Amount: 1.0 mg net (AAA)
Purity: >95% (HPLC-MS)
Counterion: TFA
Delivery Format: Freeze-dried in plastic vial
Chemical formula: C129H211N35O48
MW (average): 3020.3
Application(s): Diabetes research
Condition(s)/Topic(s): Diabetes
Standard Delivery Time: 2-5 days
CAS: 33017-11-7
SMILES: O=C(NCC(N1CCC[C@H]1C(NCC(N[C@@H](C)C(NCC(N[C@@H](CO)C(N[C@@H](CC(C)C)C(N[C@@H](CCC(N)=O)C(N2CCC[C@H]2C(N[C@@H](CC(C)C)C(N[C@@H](C)C(N[C@@H](CC(C)C)C(N[C@@H](CCC(O)=O)C(NCC(N[C@@H](CO)C(N[C@@H](CC(C)C)C(N[C@@H](CCC(N)=O)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CNC(CNC([C@H](CC(C)C)NC([C@H](CCC(O)=O)NC([C@H](C(C)C)NC([C@H](CCC(N)=O)NC(CNC([C@H](C(C)C)NC([C@H](CCC(N)=O)NC([C@H](CC(C)C)NC([C@H](CC(O)=O)NC([C@H](CCC(O)=O)NC([C@H](C)NC([C@H](CCC(O)=O)N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O

Are you interested in other peptides or conjugation to a protein, nucleic acid or lipid? Choose your sequence, amount and purity with our Custom Peptide Synthesis services.

JPT’s C-Peptide (human) - connecting peptide

JPT Peptide Technologies has substantial, long-standing expertise in providing peptides in all formats, scales and modifications to the global scientific community. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.

Benefits of JPT’s Peptides

All peptides are made in Germany
Bulk orders or custom peptide synthesis upon request
Provision of freeze-dried aliquots for enhanced stability
Proven track record
Need the conjugated or modified peptide? Contact us!

References

References for C-Peptide, Human, CAS: 33017-11-7

References:
Read References with Specialty Peptides

Testimonial:
"Our group focuses on the in vitro study of risk factors in Alzheimer’s disease and, as we experienced that the in-house expression and production of the amyloid beta peptide is notoriously difficult, we are continuously dependent on a high quality supply of a large variety of these peptides from commercial source.We started our collaboration with JPT with their request to test a range of their peptides for the ability to produce toxic oligomers and fibrillar networks and were impressed by the rapid supply of a very wide range of high purity peptides with excellent fibril forming properties and toxicity profiles. JPT has shown real valuable know-how and experience in the field of peptide synthesis by their ability to generate high quality preparations of amyloid beta peptide variants which are known for their difficulty to handle."
Kerensa Broersen, Assistant Prof., Nanobiophysics Group, University of Twente, Enschede, The Netherlands

Testimonial:
Our group focuses on the in vitro study of risk factors in Alzheimer’s disease and, as we experienced that the in-house expression and production of the amyloid beta peptide is notoriously difficult, we are continuously dependent on a high quality supply of a large variety of these peptides from commercial source.We started our collaboration with JPT with their request to test a range of their peptides for the ability to produce toxic oligomers and fibrillar networks and were impressed by the rapid supply of a very wide range of high purity peptides with excellent fibril forming properties and toxicity profiles. JPT has shown real valuable know-how and experience in the field of peptide synthesis by their ability to generate high quality preparations of amyloid beta peptide variants which are known for their difficulty to handle.
Kerensa Broersen, Assistant Prof., Nanobiophysics Group, University of Twente, Enschede, The Netherlands

Properties

Properties of C-Peptide, Human, CAS: 33017-11-7

Properties	Values
Amount:	1.0 mg net (AAA)
Application:	Diabetes research
Category:	Diabetes Peptides
Condition / Topic:	Diabetes
Layout:	Freeze-dried in plastic vial
Organism:	Human
Protein Name:	Diabetes Peptide
Purity:	>95% (HPLC-MS)
Quantification:	Yes

Further Information to C-Peptide, Human, CAS: 33017-11-7

Information	Values
Sequence:	H-EAEDLQVGQVELGGGPGAGSLQPLALEGSLQ-OH